SAM
GOSS icon

Silvercrest Asset Management’s Gossamer Bio GOSS Stock Holding History

Silvercrest Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-327
Closed -$32.2K – 844
2025
Q2 		$32.2K Hold
327
– – ﹤0.01% 834
2025
Q1 		$28.8K Hold
327
– – ﹤0.01% 837
2024
Q4 		$23.7K Hold
327
– – ﹤0.01% 821
2024
Q3 		$25.8K Buy
327
+78
+31% +$6K ﹤0.01% 797
2024
Q2 		$17.9K Hold
249
– – ﹤0.01% 895
2024
Q1 		$23.5K Hold
249
– – ﹤0.01% 882
2023
Q4 		$18.2K Hold
249
– – ﹤0.01% 833
2023
Q3 		$16.6K Hold
249
– – ﹤0.01% 825
2023
Q2 		$23.9K Buy
+249
New +$24.8K ﹤0.01% 816

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Silvercrest Asset Management's GOSS Position: Q3 2025 in Review

Silvercrest Asset Management sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 327 shares — an estimated $32.2K sold.

Silvercrest Asset Management first reported a position in GOSS in Q2 2023 and held it in 9 quarters. The position peaked at $32.2K in Q2 2025. 162 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Silvercrest Asset Management reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • Silvercrest Asset Management sold 327 Gossamer Bio shares in Q3 2025, an estimated $32.2K.
  • Silvercrest Asset Management first reported a position in Gossamer Bio in Q2 2023 and held it in 9 quarters.
  • Silvercrest Asset Management's Gossamer Bio position peaked at $32.2K in Q2 2025.
  • 162 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Silvercrest Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.